A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- N/A
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
- Status
- COMPLETED
- Phase
- PHASE1
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- Status
- RECRUITING
- Phase
- PHASE1
Ascorbic Acid Levels in MDS, AML, and CMML Patients
- Status
- COMPLETED
- Phase
- N/A
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
- Status
- COMPLETED
- Phase
- PHASE2
Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- N/A
SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Status
- RECRUITING
- Phase
- N/A
iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
- Status
- WITHDRAWN
- Phase
- NA
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT
- Status
- RECRUITING
- Phase
- PHASE2
RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
- Status
- UNKNOWN
- Phase
- PHASE2
Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia
- Status
- UNKNOWN
- Phase
- NA
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
- Status
- COMPLETED
- Phase
- PHASE2